David Westenberg
Stock Analyst at Piper Sandler
(4.71)
# 157
Out of 5,115 analysts
188
Total ratings
61.68%
Success rate
27.81%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Overweight | $150 | $86.34 | +73.73% | 1 | Dec 1, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $15 → $19 | $16.72 | +13.64% | 3 | Nov 11, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $105 → $80 | $64.26 | +24.49% | 6 | Nov 11, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $1.5 → $2 | $1.88 | +6.38% | 10 | Nov 11, 2025 | |
| NTRA Natera | Maintains: Overweight | $220 → $230 | $235.54 | -2.35% | 17 | Nov 11, 2025 | |
| FLGT Fulgent Genetics | Maintains: Neutral | $21 → $30 | $27.01 | +11.07% | 10 | Nov 11, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $70 → $80 | $101.54 | -21.21% | 13 | Nov 11, 2025 | |
| CTKB Cytek Biosciences | Maintains: Overweight | $8 → $7.5 | $5.06 | +48.22% | 10 | Nov 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $200 | $175.92 | +13.69% | 8 | Oct 27, 2025 | |
| GH Guardant Health | Maintains: Overweight | $60 → $90 | $102.38 | -12.09% | 10 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 → $6.5 | $7.14 | -8.96% | 13 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.68 | +19.90% | 15 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $140 | $136.09 | +2.87% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $215 | $125.49 | +71.33% | 15 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $510 → $700 | $688.18 | +1.72% | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $18 | $22.38 | -19.57% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $11 | $12.30 | -10.57% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $185 | $135.32 | +36.71% | 16 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $260 → $280 | $254.46 | +10.04% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $28.98 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $37.50 | - | 1 | Nov 21, 2017 |
BillionToOne
Dec 1, 2025
Initiates: Overweight
Price Target: $150
Current: $86.34
Upside: +73.73%
10x Genomics
Nov 11, 2025
Maintains: Neutral
Price Target: $15 → $19
Current: $16.72
Upside: +13.64%
Tempus AI
Nov 11, 2025
Maintains: Neutral
Price Target: $105 → $80
Current: $64.26
Upside: +24.49%
Pacific Biosciences of California
Nov 11, 2025
Maintains: Neutral
Price Target: $1.5 → $2
Current: $1.88
Upside: +6.38%
Natera
Nov 11, 2025
Maintains: Overweight
Price Target: $220 → $230
Current: $235.54
Upside: -2.35%
Fulgent Genetics
Nov 11, 2025
Maintains: Neutral
Price Target: $21 → $30
Current: $27.01
Upside: +11.07%
Exact Sciences
Nov 11, 2025
Maintains: Overweight
Price Target: $70 → $80
Current: $101.54
Upside: -21.21%
Cytek Biosciences
Nov 11, 2025
Maintains: Overweight
Price Target: $8 → $7.5
Current: $5.06
Upside: +48.22%
Quest Diagnostics
Oct 27, 2025
Maintains: Neutral
Price Target: $190 → $200
Current: $175.92
Upside: +13.69%
Guardant Health
Oct 22, 2025
Maintains: Overweight
Price Target: $60 → $90
Current: $102.38
Upside: -12.09%
Oct 16, 2025
Reiterates: Neutral
Price Target: $5 → $6.5
Current: $7.14
Upside: -8.96%
Oct 15, 2025
Maintains: Overweight
Price Target: $15 → $20
Current: $16.68
Upside: +19.90%
Sep 11, 2025
Maintains: Overweight
Price Target: $120 → $140
Current: $136.09
Upside: +2.87%
Aug 11, 2025
Maintains: Overweight
Price Target: $210 → $215
Current: $125.49
Upside: +71.33%
Aug 11, 2025
Maintains: Neutral
Price Target: $510 → $700
Current: $688.18
Upside: +1.72%
Aug 11, 2025
Maintains: Neutral
Price Target: $12 → $18
Current: $22.38
Upside: -19.57%
Aug 4, 2025
Maintains: Overweight
Price Target: $12 → $11
Current: $12.30
Upside: -10.57%
May 15, 2025
Maintains: Overweight
Price Target: $190 → $185
Current: $135.32
Upside: +36.71%
May 6, 2025
Maintains: Neutral
Price Target: $260 → $280
Current: $254.46
Upside: +10.04%
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $28.98
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $37.50
Upside: -